Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyoscine Butylbromide Tablets vs Capsules for Abdominal Spasm Pain
NCT02242305Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Nov 2008
- Primary completion
- Jul 2009
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of hyoscine butylbromide in abdominal pain and intestinal spasm (2 arms), sponsored by Boehringer Ingelheim. Primary endpoint: Change of the Mean Pain Intensity Score Measured on a Visual Analogue Scale at 1 day. Started Nov 2008; status: completed.
02
Drugs
hyoscine butylbromide
03
Conditions
abdominal painintestinal spasm
Beyond the preview
Go deeper on NCT02242305.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02242305.